Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China flag China · Delayed Price · Currency is CNY
7.31
-0.01 (-0.14%)
Apr 29, 2026, 3:04 PM CST

SHE:002349 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,4601,3881,4961,5501,336
Other Revenue
-13.6315.4122.5821.41
1,4601,4021,5121,5731,358
Revenue Growth (YoY)
4.13%-7.25%-3.90%15.85%5.97%
Cost of Revenue
702.4719.73781.18847.06739.21
Gross Profit
757.56682.36730.58726618.66
Selling, General & Admin
394.33366.72346.78401.01352.64
Research & Development
64.9961.7964.6286.9874.76
Other Operating Expenses
13.8817.4817.7722.3920.17
Operating Expenses
473.65449.36431.89514.64462.16
Operating Income
283.91233298.69211.36156.51
Interest Expense
-0.57-1.34-2.57-6.79-12.94
Interest & Investment Income
30.348.3823.8739.7114.16
Currency Exchange Gain (Loss)
-2.342.356.86-1.48
Other Non Operating Income (Expenses)
-3.44-0.30.43-1.241.45
EBT Excluding Unusual Items
310.19282.09322.76249.9157.7
Gain (Loss) on Sale of Investments
4.173.826.834.9931.44
Gain (Loss) on Sale of Assets
-0.01-0.2-0.09-0.06-0.58
Asset Writedown
-10.75-2.13-4.52-16.96-16.7
Other Unusual Items
-9.754.7112.347.03
Pretax Income
303.61293.32329.7250.21178.89
Income Tax Expense
41.7745.8553.2337.9238.93
Earnings From Continuing Operations
261.84247.47276.47212.29139.96
Minority Interest in Earnings
-42.55-34.81-28.77-0.0620.74
Net Income
219.28212.65247.7212.23160.7
Net Income to Common
219.28212.65247.7212.23160.7
Net Income Growth
3.12%-14.15%16.71%32.06%44.79%
Shares Outstanding (Basic)
819814814814814
Shares Outstanding (Diluted)
819814814814814
Shares Change (YoY)
0.58%-0.01%0.02%-0.00%-0.03%
EPS (Basic)
0.270.260.300.260.20
EPS (Diluted)
0.270.260.300.260.20
EPS Growth
2.53%-14.13%16.69%32.07%44.83%
Free Cash Flow
320.54280.1262.93296.8225.02
Free Cash Flow Per Share
0.390.340.320.360.28
Dividend Per Share
-0.0790.0920.0800.060
Dividend Growth
--14.67%15.00%33.33%46.34%
Gross Margin
51.89%48.67%48.33%46.15%45.56%
Operating Margin
19.45%16.62%19.76%13.44%11.53%
Profit Margin
15.02%15.17%16.38%13.49%11.83%
Free Cash Flow Margin
21.96%19.98%17.39%18.87%16.57%
EBITDA
363.51307.95382.89319.43257.8
EBITDA Margin
24.90%21.96%25.33%20.31%18.99%
D&A For EBITDA
79.674.9484.21108.07101.29
EBIT
283.91233298.69211.36156.51
EBIT Margin
19.45%16.62%19.76%13.44%11.53%
Effective Tax Rate
13.76%15.63%16.14%15.16%21.76%
Revenue as Reported
1,4601,4021,5121,5731,358
Advertising Expenses
-13.6913.657.2711.6
Source: S&P Global Market Intelligence. Standard template. Financial Sources.